Company / Free Cash Flow per Share
Amgen Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$15.09
FY2025
5-year range
$13.78 / $19.41
FY2021-FY2025
Trend
-22.3%
vs FY2024
Sector context
#5 of 192
Health Care
What the data says
Among 192 Health Care companies, Amgen is in the top 3% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $10.92 in FY2016 to $19.41 in FY2024.
Based on SEC 10-K filings.
15.09 in FY2025 with a 5-year CAGR of -3.3%. Top quartile in the Health Care sector.
Improved from $13.78 to $15.09 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -5.2%
- 5-Year CAGR
- -3.3%
- 10-Year CAGR
- -
Sector benchmark
+176.0% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 22.3% year-over-year.
- Ranks #5 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.09 | -22.3% |
| FY2024 | $19.41 | +40.9% |
| FY2023 | $13.78 | -22.2% |
| FY2022 | $17.71 | +20.1% |
| FY2021 | $14.75 | -17.4% |
| FY2020 | $17.85 | +6.9% |
| FY2019 | $16.70 | +25.4% |
| FY2018 | $13.31 | +7.6% |
| FY2017 | $12.38 | +13.3% |
| FY2016 | $10.92 | -9.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026